Home About Us Our People Scientific Advisory Committee

Scientific Advisory Committee

Cure Brain Cancer Foundation’s internationally-renowned Scientific Advisory Committee is an expert group of brain cancer researchers and clinicians with the important role of ensuring the organisation only funds the highest quality research that will deliver the greatest impact for people with brain cancer.

Ensuring Research Excellence

We are committed to ensuring our Scientific Advisory Committee is of the highest calibre. Each member must be able to make decisions about research in an international context and provide a transparent, impartial platform for decision-making. This ensures good governance and safeguards best practice in research funding.

The strength and competence of our Committee is testament to our commitment to responsibly and impartially funding the best research with the best chance of success.

A/Prof Hao-Wen Sim

Medical Oncologist

The Kinghorn Cancer Centre, Chris O’Brien Lifehouse and NHMRC Clinical Trials Centre

Prof Jordan R. Hansford

Lead in Paediatric Neuro-Oncology

Women’s and Children’s Hospital

Lead of the Paediatric Neuro-Oncology Group

South Australia Health and Medical Research Institute

Prof Lenka Munoz

Head of the Glioblastoma Drug Discovery

Charles Perkins Centre, University of Sydney

A/Prof Mastura Monif

Head of Neuroimmunology, Neuroinflammation and Neuro Oncology

Monash University Department of Neuroscience

Prof Petra Hamerlik

Chair of Translational Neuro-Oncology

The University of Manchester

Prof Stuart Pitson

NRF Professor of Brain Tumour Research and Head of the Molecular Therapeutics Laboratory

Centre for Cancer Biology, University of South Australia

A/Prof Theo Mantamadiotis

Head of the Brain Cancer Biology & Tumour Microenvironment Laboratory

The University of Melbourne and Doherty Institute

Dr Alan Olivero, PhD

President

Olivero Consulting Inc. San Francisco

Former Head of Research Operations

Genentech

Dr Helen Wheeler

Head of Medical Oncology

Royal North Shore and Head of the Medical Oncology clinical trials unit

Prof Hui Gan, Ph.D

Clinical Research Lead

Olivia Newton John Cancer Research Institute Executive Team

Clinician Scientist

Tumour Targeting Laboratory

Prof Bryan Day, Ph.D

Professor and Group Leader

Sid Faithfull Brain Cancer Laboratory

A/Prof. Hao-Wen Sim

Medical Oncologist

The Kinghorn Cancer Centre, Chris O’Brien Lifehouse and NHMRC Clinical Trials Centre

Prof. Jordan R. Hansford

Lead in Paediatric Neuro-Oncology

Women’s and Children’s Hospital and

Lead of the Paediatric Neuro-Oncology Group

South Australia Health and Medical Research Institute

Prof. Lenka Munoz

Head of the Glioblastoma Drug Discovery

Charles Perkins Centre, University of Sydney

A/Prof. Mastura Monif

Head of Neuroimmunology, Neuroinflammation and Neuro Oncology

Monash University Department of Neuroscience

Prof. Petra Hamerlik

Chair of Translational Neuro-Oncology

The University of Manchester

Prof. Stuart Pitson

NRF Professor of Brain Tumour Research and Head of the Molecular Therapeutics Laboratory

Centre for Cancer Biology, University of South Australia

A/Prof. Theo Mantamadiotis

Head of the Brain Cancer Biology & Tumour Microenvironment Laboratory

The University of Melbourne and Doherty Institute

Dr. Alan Olivero, PhD

President

Olivero Consulting Inc. San Francisco

Former Head of Research Operations

Genentech

Dr. Helen Wheeler

Head of Medical Oncology

Royal North Shore and Head of the Medical Oncology clinical trials unit

Prof. Hui Gan, PhD

Clinical Research Lead

Olivia Newton John Cancer Research Institute Executive Team

Clinician Scientist

Tumour Targeting Laboratory

Prof. Bryan Day, PhD

Professor and Group Leader

Sid Faithfull Brain Cancer Laboratory